Monica Metea, as the Founder of Preclinical Electrophysiology Consulting, LLC, brings a wealth of expertise in neuroscience and electrophysiology, positioning her as a pivotal figure in the realm of preclinical drug development. With a robust background in both scientific and business leadership roles within contract...
Monica Metea, as the Founder of Preclinical Electrophysiology Consulting, LLC, brings a wealth of expertise in neuroscience and electrophysiology, positioning her as a pivotal figure in the realm of preclinical drug development. With a robust background in both scientific and business leadership roles within contract research organizations, Monica has honed her skills in supporting non-clinical pharmaceutical development and agrochemical registration. Her extensive experience encompasses in vivo preclinical drug safety electrophysiology assays, where she specializes in seizure derisking across a diverse array of therapeutic targets.
At Preclinical Electrophysiology Consulting, LLC, Monica leads a team dedicated to providing tailored scientific services that meet the unique needs of pharmaceutical companies, biotech firms, and CROs. Her proficiency in neuropharmacology and assay development allows her to design and implement innovative studies that advance drug safety and efficacy. By leveraging her deep understanding of pharmacokinetics and regulatory affairs, Monica ensures that her clients navigate the complexities of drug development with confidence.
Key projects under her leadership have included collaborations with industry partners to develop robust electrophysiological assays that assess drug interactions and neurotoxicity, ultimately contributing to safer therapeutic options. Monica's commitment to excellence in scientific consulting is complemented by her strong foundation in immunology and infectious diseases, enabling her to address multifaceted challenges in drug development. Through her visionary leadership, Preclinical Electrophysiology Consulting continues to set the standard for scientific rigor and innovation in the field, making significant strides in the advancement of neuroscience research and drug development.
